Arcadis: Large contract in Resilience. ASM International: Highlights from CFO roadshow. Exor: Exor buying back Exor shares. Fastned: 2H24 results, cost pressure. Flow Traders: February volumes elevated in EMEA. Montea: JV with Weerts in Belgium. Sligro: FY24 results in line, weak 1Q25 outlook. Sofina: Final NAV a tad higher. Umicore: CMD targets – no big bang
Fastned published its FY24 annual report this morning. The top line and gross margin had already been communicated, with revenue reaching EUR86.7m (vs cons. at 86m) and 79% gross margin (vs 74% FY23), Fastned reported a positive but lower-than-expected EBITDA at EUR7.4m (-50% vs cons. of EUR14.8m,
EQS-News: JOST Werke SE / Key word(s): Annual Results/Dividend JOST slightly increases earnings after taxes in financial year 2024 and proposes a dividend of EUR 1.50 per share 26.03.2025 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. JOST slightly increases earnings after taxes in financial year 2024 and proposes a dividend of EUR 1.50 per share JOST confirms preliminary results: Forecast for the 2024 financial year achieved Sales development in line with expectations: Sales of EUR 1,069 million (2023: EUR 1,250 million) Earnin...
EQS-News: JOST Werke SE / Schlagwort(e): Jahresergebnis/Dividende JOST steigert Ergebnis nach Steuern im Geschäftsjahr 2024 leicht und schlägt eine Dividende von 1,50 EUR je Aktie vor 26.03.2025 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. JOST steigert Ergebnis nach Steuern im Geschäftsjahr 2024 leicht und schlägt eine Dividende von 1,50 EUR je Aktie vor JOST bestätigt vorläufige Ergebnisse: Prognose für das Geschäftsjahr 2024 erreicht Umsatzentwicklung innerhalb der Erwartungen: Umsatz bei 1.069 Mio. EUR (2023: 1.250 Mi...
Alfen's 4Q24 results were broadly in line with our expectations, but with the new medium-term objectives as well as the more specific 2025 guidance undershooting our below consensus expectations. We therefore cut our 2025-26 revenue estimates by 11% and 14% and our EBITDA estimates by 28% and 24% respectively. Management did bite the bullet and provided more cautious end market growth prospects for the different business segments. Equally importantly, several cost actions were taken that should ...
Arcadis: Further in German rail. CVC Capital Partners: They beat, they score. D'Ieteren: US Belron peer Boyd 4Q24 a bit ahead, weak 2025 early outlook. Fastned: Preview FY24. IBA: 2H24 better REBIT, net cash but outlook on the low side. Proximus: Interim leadership announced. UCB: Peer Immunovant reports mixed results in gMG Zabka: Peer Jeronimo Martins FY24 results
A director at Atos SE bought 35,761,900 shares at 0.002EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
This morning, Alfen announced that Michelle Lesh, who has served as Alfen's CCO since 2021, has decided to step down from her role, effective 31st March 2025. Over the past four years, Michelle was instrumental in leading Alfen’s commercial and business development efforts across all three of its b
Atos launches a reverse stock split Press release Atos launches a reverse stock split Paris, France - March 7, 2025. – Atos SE (the “Company”) announces the implementation of a reverse stock split of the shares comprising its share capital, through the exchange of 10,000 old shares of €0.0001 par value for 1 new share of €1.00 par value. Given the number of Atos shares issued during the capital increases carried out as part of the Company’s accelerated safeguard plan and the low share value, the reverse stock split aims to restore a normal number of shares, reduce share price volatility ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.